TREATED BY 177LUTETIUM-PSMA-617 (LU-PSMA)

Clinical trials for TREATED BY 177LUTETIUM-PSMA-617 (LU-PSMA) explained in plain language.

Never miss a new study

Get alerted when new TREATED BY 177LUTETIUM-PSMA-617 (LU-PSMA) trials appear

Sign up with your email to follow new studies for TREATED BY 177LUTETIUM-PSMA-617 (LU-PSMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Searching for a crystal ball for prostate cancer treatment

Knowledge-focused Recruiting now

This study aims to find molecular markers in a patient's original tumor tissue that can predict whether their advanced prostate cancer will respond to a targeted radiation treatment called Lu-PSMA. Researchers will analyze DNA and RNA from tumor samples of 120 men with metastatic…

Matched conditions: TREATED BY 177LUTETIUM-PSMA-617 (LU-PSMA)

Phase: NA • Sponsor: Centre Jean Perrin • Aim: Knowledge-focused

Last updated Apr 04, 2026 05:20 UTC

TREATED BY 177LUTETIUM-PSMA-617 (LU-PSMA)

Get alerted when new TREATED BY 177LUTETIUM-PSMA-617 (LU-PSMA) trials appear

Searching for a crystal ball for prostate cancer treatment